New combo therapy targets lung cancer brain spread

NCT ID NCT07304739

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a combination of furmonertinib (a targeted pill), chemotherapy injected into the spine, and precise radiation for people with a specific type of lung cancer (EGFR mutation) that has spread to the brain and its lining. The goal is to see if this approach can control the cancer in the brain and help people live longer. About 30 adults who have not had prior treatment will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Meningeal Carcinomatosis non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CANGZHOU People's Hospital

    RECRUITING

    Cangzhou, Hebei, 061001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin Huanhu Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300350, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin medical university cancer hospital and institute

    RECRUITING

    Tianjin, Tianjin Municipality, 300060, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••